GLP-1 receptor agonists significantly improve metabolic outcomes in type 2 diabetes patients, with notable reductions in HbA1c, body weight, and body fat. External eating behavior may predict greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback